BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18809912)

  • 1. Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors.
    Roseti C; Martinello K; Fucile S; Piccari V; Mascia A; Di Gennaro G; Quarato PP; Manfredi M; Esposito V; Cantore G; Arcella A; Simonato M; Fredholm BB; Limatola C; Miledi R; Eusebi F
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15118-23. PubMed ID: 18809912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockage of A2A and A3 adenosine receptors decreases the desensitization of human GABA(A) receptors microtransplanted to Xenopus oocytes.
    Roseti C; Palma E; Martinello K; Fucile S; Morace R; Esposito V; Cantore G; Arcella A; Giangaspero F; Aronica E; Mascia A; Di Gennaro G; Quarato PP; Manfredi M; Cristalli G; Lambertucci C; Marucci G; Volpini R; Limatola C; Eusebi F
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15927-31. PubMed ID: 19721003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation.
    Palma E; Ragozzino D; Di Angelantonio S; Mascia A; Maiolino F; Manfredi M; Cantore G; Esposito V; Di Gennaro G; Quarato P; Miledi R; Eusebi F
    Epilepsia; 2007 Oct; 48(10):1842-9. PubMed ID: 17521347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A2A receptors regulate the extracellular accumulation of excitatory amino acids upon metabolic dysfunction in chick cultured retinal cells.
    Rego AC; Agostinho P; Melo J; Cunha RA; Oliveira CR
    Exp Eye Res; 2000 May; 70(5):577-87. PubMed ID: 10870516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.
    De Sarro G; Donato Di Paola E; Falconi U; Ferreri G; De Sarro A
    Eur J Pharmacol; 1996 Dec; 317(2-3):239-45. PubMed ID: 8997606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes.
    Marchi M; Raiteri L; Risso F; Vallarino A; Bonfanti A; Monopoli A; Ongini E; Raiteri M
    Br J Pharmacol; 2002 Jun; 136(3):434-40. PubMed ID: 12023946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition.
    Lopes LV; Cunha RA; Kull B; Fredholm BB; Ribeiro JA
    Neuroscience; 2002; 112(2):319-29. PubMed ID: 12044450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.
    Ongini E; Dionisotti S; Gessi S; Irenius E; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):7-10. PubMed ID: 9933143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA(A)-current rundown of temporal lobe epilepsy is associated with repetitive activation of GABA(A) "phasic" receptors.
    Palma E; Roseti C; Maiolino F; Fucile S; Martinello K; Mazzuferi M; Aronica E; Manfredi M; Esposito V; Cantore G; Miledi R; Simonato M; Eusebi F
    Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20944-8. PubMed ID: 18083839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatase inhibitors remove the run-down of gamma-aminobutyric acid type A receptors in the human epileptic brain.
    Palma E; Ragozzino DA; Di Angelantonio S; Spinelli G; Trettel F; Martinez-Torres A; Torchia G; Arcella A; Di Gennaro G; Quarato PP; Esposito V; Cantore G; Miledi R; Eusebi F
    Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10183-8. PubMed ID: 15218107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection induced by adenosine A1 receptor agonists in a cardiac cell ischemia model involves cooperative activation of adenosine A2A and A2B receptors by endogenous adenosine.
    Urmaliya VB; Church JE; Coupar IM; Rose'Meyer RB; Pouton CW; White PJ
    J Cardiovasc Pharmacol; 2009 May; 53(5):424-33. PubMed ID: 19333129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release.
    Kurokawa M; Kirk IP; Kirkpatrick KA; Kase H; Richardson PJ
    Br J Pharmacol; 1994 Sep; 113(1):43-8. PubMed ID: 7812630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide mediates interactions between GABAA receptors and adenosine A1 receptors in the rat hippocampus.
    Fragata IR; Ribeiro JA; Sebastião AM
    Eur J Pharmacol; 2006 Aug; 543(1-3):32-9. PubMed ID: 16831416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic GABAB and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones.
    Shen KZ; Johnson SW
    J Physiol; 1997 Nov; 505 ( Pt 1)(Pt 1):153-63. PubMed ID: 9409479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat.
    Florán B; Barajas C; Florán L; Erlij D; Aceves J
    Neuroscience; 2002; 115(3):743-51. PubMed ID: 12435413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamineD1 receptor interaction in rat brain limbic regions but not basal ganglia.
    Mayfield RD; Jones BA; Miller HA; Simosky JK; Larson GA; Zahniser NR
    Synapse; 1999 Sep; 33(4):274-81. PubMed ID: 10421708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF modulates GABAA receptors microtransplanted from the human epileptic brain to Xenopus oocytes.
    Palma E; Torchia G; Limatola C; Trettel F; Arcella A; Cantore G; Di Gennaro G; Manfredi M; Esposito V; Quarato PP; Miledi R; Eusebi F
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1667-72. PubMed ID: 15665077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
    Kim YC; de Zwart M; Chang L; Moro S; von Frijtag Drabbe Künzel JK; Melman N; IJzerman AP; Jacobson KA
    J Med Chem; 1998 Jul; 41(15):2835-45. PubMed ID: 9667972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A1 and A2A receptor activation by endogenous adenosine is required for VIP enhancement of K+ -evoked [3H]-GABA release from rat hippocampal nerve terminals.
    Cunha-Reis D; Ribeiro JA; Sebastião AM
    Neurosci Lett; 2008 Jan; 430(3):207-12. PubMed ID: 18054436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.